{"parse":{"title":"Lucinactant","pageid":25933137,"revid":812668316,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em;border-spacing:2px;\"><caption><span title=\"International nonproprietary name (INN): Lucinactant\">Lucinactant</span></caption><tbody><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Combination of</th></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Clinical data</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Drug_nomenclature#Trade_names\" title=\"Drug nomenclature\">Trade names</a></th><td>\nSurfaxin</td></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/Anatomical_Therapeutic_Chemical_Classification_System\" title=\"Anatomical Therapeutic Chemical Classification System\">ATC code</a></th><td>\n<div class=\"plainlist\"><ul><li><a href=\"/wiki/ATC_code_R07\" title=\"ATC code R07\">R07AA30</a>&#x20;(<span title=\"www.whocc.no\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.whocc.no/atc_ddd_index/?code=R07AA30\">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan=\"2\" style=\"text-align:center;background:#ddd\">Identifiers</th></tr><tr><th scope=\"row\" style=\"padding:0.2em 0; line-height:1.2em;\"><a href=\"/wiki/CAS_Registry_Number\" title=\"CAS Registry Number\">CAS Number</a></th><td>\n<div class=\"plainlist\"><ul><li><span title=\"www.commonchemistry.org\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.commonchemistry.org/ChemicalDetail.aspx?ref=825600-90-6\">825600-90-6</a></span></li></ul></div></td></tr></tbody></table>\n<p><b>Lucinactant</b> (trade name <b>Surfaxin</b>) is a liquid medication used to treat <a href=\"/wiki/Infant_respiratory_distress_syndrome\" title=\"Infant respiratory distress syndrome\">infant respiratory distress syndrome</a>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup> It is a <a href=\"/wiki/Pulmonary_surfactant\" title=\"Pulmonary surfactant\">pulmonary surfactant</a> for infants who lack enough natural surfactant in their lungs. Whereas earlier medicines of the class, such as <a href=\"/wiki/Beractant\" title=\"Beractant\">beractant</a>, <a href=\"/wiki/Calfactant\" title=\"Calfactant\">calfactant</a>, and poractant, are derived from animals, lucinactant is <a href=\"/wiki/Organic_synthesis\" title=\"Organic synthesis\">synthetic</a>. It was approved for use in the United States by the U.S. Food and Drug Administration (FDA) on March 6, 2012.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_uses\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical uses</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Chemistry\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Chemistry</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#History\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Legal_status\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Legal status</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Medical_uses\">Medical uses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Lucinactant&amp;action=edit&amp;section=1\" title=\"Edit section: Medical uses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Lucinactant is indicated to improve lung function and reduce duration and risk of <a href=\"/wiki/Mechanical_ventilation\" title=\"Mechanical ventilation\">mechanical ventilation</a> in children. It can be used up to two years of age and is specified for children who are diagnosed with acute <a href=\"/wiki/Respiratory_failure\" title=\"Respiratory failure\">respiratory failure</a> following exposure to a pathogen such as <a href=\"/wiki/Human_respiratory_syncytial_virus\" title=\"Human respiratory syncytial virus\">RSV</a> or <a href=\"/wiki/Influenza\" title=\"Influenza\">influenza</a>, including <a href=\"/wiki/H1N1\" class=\"mw-redirect\" title=\"H1N1\">H1N1</a>.<sup id=\"cite_ref-POPG,_a_Key_Component_of_Discovery_Labs&#39;_KL4_Surfactant,_Identified_as_a_Novel_Anti-Viral_Therapeutic_Approach_3-0\" class=\"reference\"><a href=\"#cite_note-POPG,_a_Key_Component_of_Discovery_Labs&#39;_KL4_Surfactant,_Identified_as_a_Novel_Anti-Viral_Therapeutic_Approach-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Bronchopulmonary_segmental_lavage_with_Surfaxin_(KL(4)-surfactant)_for_acute_respiratory_distress_syndrome._4-0\" class=\"reference\"><a href=\"#cite_note-Bronchopulmonary_segmental_lavage_with_Surfaxin_(KL(4)-surfactant)_for_acute_respiratory_distress_syndrome.-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome._5-0\" class=\"reference\"><a href=\"#cite_note-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome.-5\">&#91;5&#93;</a></sup> Lucinactant is also used to treat <a href=\"/wiki/Meconium_aspiration_syndrome\" title=\"Meconium aspiration syndrome\">meconium aspiration syndrome</a>.<sup id=\"cite_ref-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome._5-1\" class=\"reference\"><a href=\"#cite_note-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome.-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-A_multicenter,_randomized,_controlled_trial_comparing_Surfaxin_(Lucinactant)_lavage_with_standard_care_for_treatment_of_meconium_aspiration_syndrome._6-0\" class=\"reference\"><a href=\"#cite_note-A_multicenter,_randomized,_controlled_trial_comparing_Surfaxin_(Lucinactant)_lavage_with_standard_care_for_treatment_of_meconium_aspiration_syndrome.-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Chemistry\">Chemistry</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Lucinactant&amp;action=edit&amp;section=2\" title=\"Edit section: Chemistry\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Lucinactant contains the peptide <a href=\"/w/index.php?title=Sinapultide&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Sinapultide (page does not exist)\">sinapultide</a> (KL4 acetate), <a href=\"/wiki/Dipalmitoylphosphatidylcholine\" title=\"Dipalmitoylphosphatidylcholine\">dipalmitoylphosphatidylcholine</a> (DPPC), <a href=\"/w/index.php?title=1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (page does not exist)\">1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol</a> (POPG, as the sodium salt), and <a href=\"/wiki/Palmitic_acid\" title=\"Palmitic acid\">palmitic acid</a>.\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Lucinactant&amp;action=edit&amp;section=3\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The scientific groundwork for lucinactant was laid in the laboratory of Charles Cochrane at The <a href=\"/wiki/Scripps_Research_Institute\" title=\"Scripps Research Institute\">Scripps Research Institute</a> in the 1990s.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> The drug was then developed by Discovery Laboratories of <a href=\"/wiki/Warrington_Township,_Bucks_County,_Pennsylvania\" title=\"Warrington Township, Bucks County, Pennsylvania\">Warrington, PA</a>. The path through the approval process was unusually long, reflecting in part challenges in the manufacturing process that needed to be addressed before approval was granted.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Legal_status\">Legal status</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Lucinactant&amp;action=edit&amp;section=4\" title=\"Edit section: Legal status\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Lucinactant is listed as an <a href=\"/wiki/Orphan_drug\" title=\"Orphan drug\">Orphan Drug Product</a> by the US Food and Drug Administration for several conditions:<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p>\n<ul><li>07-30-1996\tTreatment of meconium aspiration syndrome in newborn infants</li>\n<li>07-17-1995\tTreatment of acute respiratory distress syndrome in adults.</li>\n<li>05-23-2006\tPrevention of bronchopulmonary dysplasia in premature infants</li>\n<li>10-21-2005\tTreatment of bronchopulmonary dysplasia in premature infants.</li>\n<li>10-18-1995\tTreatment of respiratory distress syndrome in premature infants.</li></ul>\n<p>Clinical trials in Latin America were criticized for protocol based in potentially unethical principles.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>  A placebo was used and considered ethical by design since infants born in Latin America usually do not have access to life saving treatment. The intent of Discovery Labs was always to market Surfaxin in the United States, implying burdens on the Latin American children that outweighed the benefits.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Lucinactant&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.discoverylabs.com/surfaxin.html\">[1]</a> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090420135625/http://www.discoverylabs.com/surfaxin.html\">Archived</a> April 20, 2009, at the <a href=\"/wiki/Wayback_Machine\" title=\"Wayback Machine\">Wayback Machine</a>.</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm294984.htm\">\"FDA approves Surfaxin to prevent breathing disorder in premature infants\"</a>. Fda.gov. 2012-03-06<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-10-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+Surfaxin+to+prevent+breathing+disorder+in+premature+infants&amp;rft.pub=Fda.gov&amp;rft.date=2012-03-06&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm294984.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-POPG,_a_Key_Component_of_Discovery_Labs&#39;_KL4_Surfactant,_Identified_as_a_Novel_Anti-Viral_Therapeutic_Approach-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-POPG,_a_Key_Component_of_Discovery_Labs&#39;_KL4_Surfactant,_Identified_as_a_Novel_Anti-Viral_Therapeutic_Approach_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"> <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20100122205312/http://money.cnn.com/news/newsfeeds/articles/globenewswire/182115.htm\">https://web.archive.org/web/20100122205312/http://money.cnn.com/news/newsfeeds/articles/globenewswire/182115.htm</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://money.cnn.com/news/newsfeeds/articles/globenewswire/182115.htm\">the original</a> on January 22, 2010.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2Fnews%2Fnewsfeeds%2Farticles%2Fglobenewswire%2F182115.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Missing or empty <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;title=</code> (<a href=\"/wiki/Help:CS1_errors#citation_missing_title\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Bronchopulmonary_segmental_lavage_with_Surfaxin_(KL(4)-surfactant)_for_acute_respiratory_distress_syndrome.-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bronchopulmonary_segmental_lavage_with_Surfaxin_(KL(4)-surfactant)_for_acute_respiratory_distress_syndrome._4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wiswell, T. E.; Smith, R. M.; Katz, L. B.; Mastroianni, L.; Wong, D. Y.; Willms, D.; Heard, S.; Wilson, M.; Hite, R. D.; Anzueto, A.; Revak, S. D.; Cochrane, C. G. (1999). \"Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome\". <i>American Journal of Respiratory and Critical Care Medicine</i>. <b>160</b> (4): 1188\u20131195. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1164/ajrccm.160.4.9808118\">10.1164/ajrccm.160.4.9808118</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10508806\">10508806</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Respiratory+and+Critical+Care+Medicine&amp;rft.atitle=Bronchopulmonary+segmental+lavage+with+Surfaxin+%28KL%284%29-surfactant%29+for+acute+respiratory+distress+syndrome&amp;rft.volume=160&amp;rft.issue=4&amp;rft.pages=1188-1195&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1164%2Fajrccm.160.4.9808118&amp;rft_id=info%3Apmid%2F10508806&amp;rft.aulast=Wiswell&amp;rft.aufirst=T.+E.&amp;rft.au=Smith%2C+R.+M.&amp;rft.au=Katz%2C+L.+B.&amp;rft.au=Mastroianni%2C+L.&amp;rft.au=Wong%2C+D.+Y.&amp;rft.au=Willms%2C+D.&amp;rft.au=Heard%2C+S.&amp;rft.au=Wilson%2C+M.&amp;rft.au=Hite%2C+R.+D.&amp;rft.au=Anzueto%2C+A.&amp;rft.au=Revak%2C+S.+D.&amp;rft.au=Cochrane%2C+C.+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome.-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome._5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lucinactant:_a_novel_synthetic_surfactant_for_the_treatment_of_respiratory_distress_syndrome._5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Donn, S. (2005). \"Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome\". <i>Expert Opinion on Investigational Drugs</i>. <b>14</b> (3): 329\u2013334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/13543784.14.3.329\">10.1517/13543784.14.3.329</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15833063\">15833063</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Investigational+Drugs&amp;rft.atitle=Lucinactant%3A+a+novel+synthetic+surfactant+for+the+treatment+of+respiratory+distress+syndrome&amp;rft.volume=14&amp;rft.issue=3&amp;rft.pages=329-334&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1517%2F13543784.14.3.329&amp;rft_id=info%3Apmid%2F15833063&amp;rft.aulast=Donn&amp;rft.aufirst=S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-A_multicenter,_randomized,_controlled_trial_comparing_Surfaxin_(Lucinactant)_lavage_with_standard_care_for_treatment_of_meconium_aspiration_syndrome.-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-A_multicenter,_randomized,_controlled_trial_comparing_Surfaxin_(Lucinactant)_lavage_with_standard_care_for_treatment_of_meconium_aspiration_syndrome._6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wiswell, T. E.; Knight, G. R.; Finer, N. N.; Donn, S. M.; Desai, H.; Walsh, W. F.; Sekar, K. C.; Bernstein, G.; Keszler, M.; Visser, V. E.; Merritt, T. A.; Mannino, F. L.; Mastrioianni, L.; Marcy, B.; Revak, S. D.; Tsai, H.; Cochrane, C. G. (2002). \"A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome\". <i>Pediatrics</i>. <b>109</b> (6): 1081\u20131087. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1542/peds.109.6.1081\">10.1542/peds.109.6.1081</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12042546\">12042546</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=A+multicenter%2C+randomized%2C+controlled+trial+comparing+Surfaxin+%28Lucinactant%29+lavage+with+standard+care+for+treatment+of+meconium+aspiration+syndrome&amp;rft.volume=109&amp;rft.issue=6&amp;rft.pages=1081-1087&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.109.6.1081&amp;rft_id=info%3Apmid%2F12042546&amp;rft.aulast=Wiswell&amp;rft.aufirst=T.+E.&amp;rft.au=Knight%2C+G.+R.&amp;rft.au=Finer%2C+N.+N.&amp;rft.au=Donn%2C+S.+M.&amp;rft.au=Desai%2C+H.&amp;rft.au=Walsh%2C+W.+F.&amp;rft.au=Sekar%2C+K.+C.&amp;rft.au=Bernstein%2C+G.&amp;rft.au=Keszler%2C+M.&amp;rft.au=Visser%2C+V.+E.&amp;rft.au=Merritt%2C+T.+A.&amp;rft.au=Mannino%2C+F.+L.&amp;rft.au=Mastrioianni%2C+L.&amp;rft.au=Marcy%2C+B.&amp;rft.au=Revak%2C+S.+D.&amp;rft.au=Tsai%2C+H.&amp;rft.au=Cochrane%2C+C.+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.scripps.edu/news/press/20120306cochrane.html\">\"Scripps Research Discoveries Lead to Newly Approved Drug for Infant Respiratory Distress Syndrome\"</a>. Scripps.edu. 2012-03-06<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-10-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Scripps+Research+Discoveries+Lead+to+Newly+Approved+Drug+for+Infant+Respiratory+Distress+Syndrome&amp;rft.pub=Scripps.edu&amp;rft.date=2012-03-06&amp;rft_id=http%3A%2F%2Fwww.scripps.edu%2Fnews%2Fpress%2F20120306cochrane.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmacychoice.com/news/article.cfm?Article_ID=854519\">\"Pharmaceutical News - Discovery Labs Turns Focus To Surfaxin Market Strategy - October 20, 2012\"</a>. Pharmacy Choice<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-10-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pharmaceutical+News+-+Discovery+Labs+Turns+Focus+To+Surfaxin+Market+Strategy+-+October+20%2C+2012&amp;rft.pub=Pharmacy+Choice&amp;rft_id=http%3A%2F%2Fwww.pharmacychoice.com%2Fnews%2Farticle.cfm%3FArticle_ID%3D854519&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://google2.fda.gov/search?q=cache:LCsiKMwG2v0J:www.fda.gov/ohrms/dockets/dailys/00/mar00/030100/lst0094.pdf+surfaxin&amp;client=FDAgov&amp;site=FDAgov&amp;lr=&amp;proxystylesheet=FDAgov&amp;output=xml_no_dtd&amp;ie=UTF-8&amp;access=p&amp;oe=UTF-8\">\"List Of Orphan Products Designations And Approvals\"</a>. Google2.fda.gov<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-10-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=List+Of+Orphan+Products+Designations+And+Approvals&amp;rft.pub=Google2.fda.gov&amp;rft_id=http%3A%2F%2Fgoogle2.fda.gov%2Fsearch%3Fq%3Dcache%3ALCsiKMwG2v0J%3Awww.fda.gov%2Fohrms%2Fdockets%2Fdailys%2F00%2Fmar00%2F030100%2Flst0094.pdf%2Bsurfaxin%26client%3DFDAgov%26site%3DFDAgov%26lr%3D%26proxystylesheet%3DFDAgov%26output%3Dxml_no_dtd%26ie%3DUTF-8%26access%3Dp%26oe%3DUTF-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.nelm.nhs.uk/en/NeLM-Area/News/485098/485446/485460/\">\"Page expired\"</a>. Nelm.nhs.uk<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-10-20</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Page+expired&amp;rft.pub=Nelm.nhs.uk&amp;rft_id=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F485098%2F485446%2F485460%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Charatan, Fred (10 March 2001). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1119782\">\"Surfactant trial in Latin American infants criticised\"</a>. <i>BMJ</i>. 7286. <b>322</b>: 575. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.322.7286.575/b\">10.1136/bmj.322.7286.575/b</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1119782\">1119782</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11238147\">11238147</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Surfactant+trial+in+Latin+American+infants+criticised&amp;rft.volume=322&amp;rft.pages=575&amp;rft.date=2001-03-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1119782&amp;rft_id=info%3Apmid%2F11238147&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.322.7286.575%2Fb&amp;rft.aulast=Charatan&amp;rft.aufirst=Fred&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1119782&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALucinactant\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1271\nCached time: 20180909111700\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.408 seconds\nReal time usage: 0.484 seconds\nPreprocessor visited node count: 3569/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 29292/2097152 bytes\nTemplate argument size: 1036/2097152 bytes\nHighest expansion depth: 14/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 16541/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.180/10.000 seconds\nLua memory usage: 4.22 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  460.585      1 -total\n 69.08%  318.169      1 Template:Drugbox\n 38.93%  179.327      1 Template:Infobox\n 28.99%  133.538      1 Template:Reflist\n 11.20%   51.590      5 Template:Cite_web\n 10.26%   47.256     15 Template:Unbulleted_list\n  8.40%   38.710      4 Template:Cite_journal\n  6.78%   31.239      1 Template:Infobox_drug/chemical_formula\n  4.07%   18.736      1 Template:Infobox_drug/maintenance_categories\n  2.93%   13.489      1 Template:Chem_molar_mass\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:25933137-0!canonical and timestamp 20180909111700 and revision id 812668316\n -->\n</div>"},"langlinks":[{"lang":"sr","url":"https://sr.wikipedia.org/wiki/Lucinaktant","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"Lucinaktant"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Lucinaktant","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Lucinaktant"}],"categories":[{"sortkey":"","hidden":"","*":"Webarchive_template_wayback_links"},{"sortkey":"","hidden":"","*":"Pages_with_citations_lacking_titles"},{"sortkey":"","hidden":"","*":"Pages_with_citations_having_bare_URLs"},{"sortkey":"*","hidden":"","*":"Articles_without_EBI_source"},{"sortkey":"*","hidden":"","*":"Chemical_pages_without_ChemSpiderID"},{"sortkey":"*","hidden":"","*":"Chemical_pages_without_DrugBank_identifier"},{"sortkey":"*","hidden":"","*":"Articles_without_KEGG_source"},{"sortkey":"*","hidden":"","*":"Articles_without_InChI_source"},{"sortkey":"*","hidden":"","*":"Articles_without_UNII_source"},{"sortkey":"","hidden":"","*":"Drugs_with_no_legal_status"},{"sortkey":"*","hidden":"","*":"Articles_containing_unverified_chemical_infoboxes"},{"sortkey":"4","hidden":"","*":"Drugs_that_are_a_combination_of_chemicals"},{"sortkey":"","*":"Drugs_acting_on_the_respiratory_system"},{"sortkey":"","*":"Pediatrics"},{"sortkey":"","*":"Respiratory_and_cardiovascular_disorders_specific_to_the_perinatal_period"}],"links":[{"ns":0,"*":"Lucinactant (data page)"},{"ns":0,"exists":"","*":"ATC code R07"},{"ns":0,"exists":"","*":"Anatomical Therapeutic Chemical Classification System"},{"ns":0,"exists":"","*":"Beractant"},{"ns":0,"exists":"","*":"CAS Registry Number"},{"ns":0,"exists":"","*":"Calfactant"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dipalmitoylphosphatidylcholine"},{"ns":0,"exists":"","*":"Drug nomenclature"},{"ns":0,"exists":"","*":"H1N1"},{"ns":0,"exists":"","*":"Human respiratory syncytial virus"},{"ns":0,"exists":"","*":"Infant respiratory distress syndrome"},{"ns":0,"exists":"","*":"Influenza"},{"ns":0,"exists":"","*":"Mechanical ventilation"},{"ns":0,"exists":"","*":"Meconium aspiration syndrome"},{"ns":0,"exists":"","*":"Organic synthesis"},{"ns":0,"exists":"","*":"Orphan drug"},{"ns":0,"exists":"","*":"Palmitic acid"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Pulmonary surfactant"},{"ns":0,"exists":"","*":"Respiratory failure"},{"ns":0,"exists":"","*":"Scripps Research Institute"},{"ns":0,"exists":"","*":"Warrington Township, Bucks County, Pennsylvania"},{"ns":0,"exists":"","*":"Wayback Machine"},{"ns":0,"*":"Sinapultide"},{"ns":0,"*":"1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol"},{"ns":12,"exists":"","*":"Help:CS1 errors"}],"templates":[{"ns":10,"exists":"","*":"Template:Drugbox"},{"ns":10,"exists":"","*":"Template:Infobox drug"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Infobox drug/title"},{"ns":10,"exists":"","*":"Template:Both"},{"ns":10,"exists":"","*":"Template:Infobox drug/licence"},{"ns":10,"exists":"","*":"Template:Infobox drug/pregnancy category"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatATC"},{"ns":10,"exists":"","*":"Template:Infobox drug/legal status"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatCASnumber"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemCID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatPubChemSID"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatIUPHARBPS"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatDrugBank"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemSpider"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatUNII"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatKEGG"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEBI"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChEMBL"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatChemDBNIAID"},{"ns":10,"exists":"","*":"Template:Infobox drug/chemical formula"},{"ns":10,"exists":"","*":"Template:Chembox Elements/molecular formula"},{"ns":10,"exists":"","*":"Template:Chem molar mass"},{"ns":10,"exists":"","*":"Template:Chem molar mass/format"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Infobox drug/formatJmol"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Button"},{"ns":10,"exists":"","*":"Template:Border-radius"},{"ns":10,"exists":"","*":"Template:Linear-gradient"},{"ns":10,"exists":"","*":"Template:Infobox drug/maintenance categories"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Webarchive"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:TemplatePar"},{"ns":828,"exists":"","*":"Module:ParameterCount"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Webarchive"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Webarchive/data"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["http://www.discoverylabs.com/surfaxin.html","https://web.archive.org/web/20090420135625/http://www.discoverylabs.com/surfaxin.html","http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm294984.htm","https://web.archive.org/web/20100122205312/http://money.cnn.com/news/newsfeeds/articles/globenewswire/182115.htm","http://money.cnn.com/news/newsfeeds/articles/globenewswire/182115.htm","//doi.org/10.1164/ajrccm.160.4.9808118","//www.ncbi.nlm.nih.gov/pubmed/10508806","//doi.org/10.1517/13543784.14.3.329","//www.ncbi.nlm.nih.gov/pubmed/15833063","//doi.org/10.1542/peds.109.6.1081","//www.ncbi.nlm.nih.gov/pubmed/12042546","http://www.scripps.edu/news/press/20120306cochrane.html","http://www.pharmacychoice.com/news/article.cfm?Article_ID=854519","http://google2.fda.gov/search?q=cache:LCsiKMwG2v0J:www.fda.gov/ohrms/dockets/dailys/00/mar00/030100/lst0094.pdf+surfaxin&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&ie=UTF-8&access=p&oe=UTF-8","http://www.nelm.nhs.uk/en/NeLM-Area/News/485098/485446/485460/","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1119782","//doi.org/10.1136/bmj.322.7286.575/b","//www.ncbi.nlm.nih.gov/pubmed/11238147","https://www.whocc.no/atc_ddd_index/?code=R07AA30","http://www.commonchemistry.org/ChemicalDetail.aspx?ref=825600-90-6"],"sections":[{"toclevel":1,"level":"2","line":"Medical uses","number":"1","index":"1","fromtitle":"Lucinactant","byteoffset":2220,"anchor":"Medical_uses"},{"toclevel":1,"level":"2","line":"Chemistry","number":"2","index":"2","fromtitle":"Lucinactant","byteoffset":5491,"anchor":"Chemistry"},{"toclevel":1,"level":"2","line":"History","number":"3","index":"3","fromtitle":"Lucinactant","byteoffset":5742,"anchor":"History"},{"toclevel":1,"level":"2","line":"Legal status","number":"4","index":"4","fromtitle":"Lucinactant","byteoffset":6698,"anchor":"Legal_status"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Lucinactant","byteoffset":8377,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Lucinactant","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q6697358"}]}}